Awesome to have Rich Lyons as our new UC Berkeley Chancellor!!! Congrats Rich Lyons !!! news.berkeley.edu/2024/04/10/ric…

Reunion with former Perera Lab members Christina Adams and Suprit Gupta at #AACR24

Excited about ⁦Frontier Medicines⁩ First-In-Class Dual ON+OFF KRAS G12C Inhibitor FMC-376 now in Phase I/II clinical trials!! frontiermeds.com/newsroom/press…

Huge congratulations to Nurix Therapeutics for providing the first clinical evidence for degrader efficacy in the brain - including a complete response in primary central nervous system lymphoma!!! A dream team tackling a huge medical need. 👏💪 #AACR2024

ir.nurixtx.com/news-releases/…

Open position:
We are hiring a postdoctoral fellow to work on autophagy and sleep in flies and rodents! Cell biology x systems neuroscience.
Exciting collaboration with Charlotte Boccara lab Charlotte Boccara

#autophagy #Drosophila
Women in Autophagy UiO - Det medisinske fakultet NCMM Centre for Cancer Cell Reprogramming

Good day for the lab, celebrating Alex Maya-Romero 's U.S. National Science Foundation-GRFP fellowship and Roberta Peruzzo's American Cancer Society ACS postdoctoral fellowship, plus NOA for a new NINDS R01!

Years after the idea and preliminary experiments, Claire Coupland's amazing structure of the endogenous vacuolar- or vesicular-ATPase in its native vesicle is now in bioRxiv
'High resolution cryo-EM of V-ATPase in native synaptic vesicles'
biorxiv.org/content/10.110…

Day 1 of the first joint Perera-Zoncu lab retreat in SantaCruz with some boardwalk amusement park rides, laser tag, lots of food… and science (tomorrow) !!

Dear colleagues in the #TME and #CellStress areas: Please retweet & advertise this meeting. It is a continuation of the successful Aegean Conference series. Great speakers, beautiful environment, ample opportunities for discussions. Several trainee travel awards available!

New work from SHUBHAM SINGH on the mechanism of lysosomal #lipid degradation and its link to neuronal health HHMI NEWS Tobias Walther, 華濤北 Bob Farese, Jr. SKI_CellBio #CellBiology #neuro #Alzheimers

Our paper on functional discovery of protein degradation and stabilization effectors with proteome-scale induced proximity screens is out in its final version! 1/ nature.com/articles/s4158… rdcu.be/dBUju

We're looking for an Executive Director for our newly launched Molecular Therapeutics Initiative UC Berkeley UC Berkeley MCB ! Come join us in translating Berkeley science into next-generation therapies and therapeutic modalities! careerspub.universityofcalifornia.edu/psp/ucb/EMPLOY…

Excellent paper on SPG20 in sensing and repair of lysosomal membrane damage, by Pinki Gahlot and HemmoMeyerLab!

Such an honor to serve as vice-chair for an incredible meeting led by Patricia Boya and Hurley Lab
Looking forward to chairing the 2026 meeting with Oliver Oliver Florey and new vice-chairs Roberto and Helene Roberto Zoncu Helene Knævelsrud
#GRCautophagy2024

🧬🔬We have a fully funded postdoc position. Details below. Please get in touch for more details!!

Great week at the #GRCAutophagy2024 . Amazing science, great discussions and fun. Thanks to co-chair Jim Hurley Hurley Lab and vice-chair Rushika M. Perera for a great team effort. Safe trip home!

Join us in welcoming Kevin Mark, Ph.D. to the Department of Cell Biology! Dr. Mark comes from UC Berkeley MCB and will be leading his own lab at UTSW. He recently was awarded a $2 million CPRIT grant to aid his research on studying protein modification by ubiquitin.

Excited to announce the Molecular Therapeutics Initiative UC Berkeley, which in the age of #InducedProximity will turn exciting biology into new therapeutic modalities for patients in need. Thank you to our generous donor, who made this possible!

businesswire.com/news/home/2024…

excited to help launch the new Molecular Therapeutics Initiative UC Berkeley MCB together with Dan Nomura and Rapé Lab!

Rapé Lab Roberto Zoncu & I are excited to announce the launch of the Molecular Therapeutics Initiative at ⁦UC Berkeley MCB⁩ catalyzed by a $10 MM gift to accelerate drug discovery by tackling the “undruggable” & discovering new therapeutic modalities!! businesswire.com/news/home/2024…